PLAINSBORO, N.J. (March 21, 2015) –
and the University of Cincinnati Cancer Institute announced today that they’ve joined forces to share news about the Institute’s latest developments through OncLive’s Strategic Alliance Partnership program.
In the new partnership, OncLive’s editorial and marketing teams will work with the University of Cincinnati Cancer Institute to highlight important advances in the research and clinical trials conducted there, as well as sharing news about its clinical practice.
The University of Cincinnati Cancer Institute oversees five centers dedicated to brain tumors, breast cancer, gastrointestinal cancer, head and neck cancer and lung cancer. Special programs focus on genitourinary cancer, gynecologic oncology and ocular oncology. The Institute also provides a palliative care program.
Its innovative survivorship program focuses on the needs of cancer survivors, including educating patients and caregivers, providing prevention strategies, and offering various approaches to rehabilitation. In addition, a new screening tool will help identify patients at risk for malnutrition, a common problem in cancer patients.
Mike J. Hennessy Jr., senior vice president, oncology & specialty pharmacy, which includes OncLive, said, “Our new partnership with the University of Cincinnati Cancer Institute will allow us to bring important cancer news to those committed to fighting this disease. Its numerous innovative treatment programs make it an important entity to watch.”
Many of those programs are the only ones of their kind in the Cincinnati area, including treatments for advanced, inoperable liver cancer and minimally invasive lung-cancer surgery. In addition, the UC Cancer Institute has been recognized as an ACR Breast Imaging Center of Excellence.
“We make a special effort to treat patients with complex and advanced disease, patients who may not find treatment elsewhere in the Cincinnati metropolitan area,” said William Barrett, MD, director of the University of Cincinnati Cancer Institute. “Our new partnership with OncLive will help us share our success stories, as well as let patients know we are here for them.”
The University of Cincinnati Cancer Institute joins more than 40 other leading cancer centers, nursing schools and physician groups around the country in partnering with OncLive.
Hennessy added, “The Strategic Alliance Partnership program serves everyone committed to fighting cancer. When we work together and share our knowledge broadly, we are better armed to improve our efforts to overcome this devastating disease.”About OncLive®OncLive.com
is the official website for Intellisphere’s Oncology Specialty Group, which publishes Oncology & Biotech News, OncologyLive, Oncology Nursing News,
and Contemporary Oncology
. OncLive offers oncology professionals resources and information they need to provide the best care for their patients. Intellisphere, LLC, a leading provider of healthcare publishing, research and education, is part of the Michael J. Hennessy Associates, Inc.
(MJH) family of businesses, based in Plainsboro, NJ. MJH also includes the acclaimed CURE Media Group, which combines science and humanity to make cancer understandable.
Its flagship product is CURETM
magazine, the largest consumer publication in the U.S. focused entirely on cancer, reaching cancer patients, cancer centers and advocacy groups. To learn more, please visit www.OncLive.com
.About the University of Cincinnati Cancer Institute
The University of Cincinnati Cancer Institute has three overarching goals: to provide the very best care to the people of Cincinnati by highly trained physicians and with personalized service; to treat patients who can’t find care for advanced and complex disease elsewhere in the area; and to conduct cutting-edge basic and clinical research that will improve the outcomes for its patients. Robot-assisted and minimally invasive surgeries are among its specialties. For more information, please visit http://uchealth.com/cancer/
###Media Contacts:For University of Cincinnati Cancer Institute:
Becky Taylor, 609.240.6886, email@example.com